Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Active substance renewal under the GB Biocidal Products Regulation (GB BPR) is a critical regulatory challenge for companies placing biocidal products on the Great Britain market. With strict 550-day submission deadlines and major expiries in 2026 and 2027, early planning is essential to avoid market disruption and loss of product authorisations.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
Learn about the South-Korean OR certificate and K-REACH pre-Registration requirements. Avoid fines and imprisonment by pre-registering your substances in South Korea before 30th June 2019. Find out how to proceed and meet the deadlines for definitive registrations.
British companies with EU REACH Authorisations must obtain UK REACH Authorisations post-Brexit. They need to inform the HSE within 60 days and provide technical information. Downstream users must also notify HSE.
ECHA extends Brexit window until 12th April, giving companies more time to appoint an Only Representative in the EU-27. Transfer your REACH responsibilities now to avoid losing registrations and authorizations post-Brexit. Prepare for Brexit now to avoid last-minute rush.
A draft regulation proposes adding 12 new substances to the REACH Annex XIV Authorisation List, pending approval by the European Parliament and Council. This list restricts the use and marketing of certain substances in the EU unless authorised.
Companies selling substances in the UK must register under UK REACH, similar to EU REACH. UK-based holders of EU registrations need to validate them post-Brexit. Different roles, such as EU manufacturers and UK importers, have specific requirements to ensure compliance.
Learn about cGMP regulations for drug products, including FDA compliance and consequences of non-compliance. Understand 21 CFR Part 210 and 211, and how to ensure cosmetic compliance in the US. Contact our experts for more information.
